257
Participants
Start Date
November 30, 2007
Primary Completion Date
July 31, 2008
Study Completion Date
July 31, 2008
indacaterol/glycopyrrolate
Inhalation capsule delivered via a single dose dry powder inhaler in the morning for 14 days.
indacaterol
Inhalation capsule delivered via a single dose dry powder inhaler in the morning for 14 days.
glycopyrrolate
Inhalation capsule delivered via a single dose dry powder inhaler in the morning for 14 days.
placebo
Inhalation capsule delivered via a single dose dry powder inhaler in the morning for 14 days.
Novartis Investigator Site, Adelaide
Novartis Investigator Site, Clayton
Novartis Investigator Site, Daw Park
Novartis Investigator site, Heidelberg
Novartis Investigator Site, Nedlands
Novartis Investigator Site, Brussels
Novartis Investigator Site, Jambes
Novartis Investigator Site, Jette
Novartis Investigator site, Liège
Novartis Investigator Site, Ostend
Novartis Investigator Site, Mississauga
Novartis Investigator Site, Newmarket
Novartis Investigator Site, Ottawa
Novartis Investigator Site, Pointe-Claire
Novartis Investigator Site, Québec
Novartis Investigator Site, Sainte-Foy
Novartis Investigator Site, Ambroise
Novartis Investigator Site, Lille
Novartis Investigator Site, Marseille
Novartis investigator site, Martigues
Novartis Investigator Site, Nantes
Novartis Investigator site, Nice
Novartis Investigator Site, Perpignan
Novartis Investigator Site, Berlin
Novartis Investigator Site, Dortmund
Novartis Investigator Site, Erfurt
Novartis Investigator Site, Hanover
Novartis Investigator Site, Mainz
Novartis Investigator Site, Marburg
Novartis Investigator Site, Florence
Novartis Investigator site, Modena
Novartis Investigator Site, Trieste
Novartis Investigator Site, Badalona
Novartis Investigator Site, Barakaldo
Novartis Investigator Site, Cáceres
Novartis Investigator Site, Centelles
Novartis Investigator Site, Mataró
Novartis Investigator Site, Valencia
Novartis Investigator Site, Istanbul
Novartis Investigator Site, Izmir
Lead Sponsor
Novartis
INDUSTRY